These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2143499)

  • 21. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
    Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise training-induced triglyceride lowering negatively correlates with DHEA levels in men with type 2 diabetes.
    Boudou P; de Kerviler E; Erlich D; Vexiau P; Gautier JF
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1108-12. PubMed ID: 11477494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution.
    Bonora E; Targher G; Branzi P; Zenere M; Saggiani F; Zenti MG; Travia D; Tonoli M; Muggeo M; Cigolini M
    Int J Obes Relat Metab Disord; 1996 Jan; 20(1):28-36. PubMed ID: 8788319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.
    Kwak JH; Ahn CW; Park SH; Jung SU; Min BJ; Kim OY; Lee JH
    Food Funct; 2012 Oct; 3(10):1019-24. PubMed ID: 22739624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fat-reducing effects of dehydroepiandrosterone involve upregulation of ATGL and HSL expression, and stimulation of lipolysis in adipose tissue.
    Karbowska J; Kochan Z
    Steroids; 2012 Nov; 77(13):1359-65. PubMed ID: 22951290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of sibutramine on blood glucose and lipids, body fat mass and insulin resistance in obese patients: a multi-center clinical trial].
    Tong NW; Ran XW; Li QF; Tang BD; Li R; Yang FY; Liu YP; Li XJ
    Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):659-63. PubMed ID: 16202254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of short-term dehydroepiandrosterone supplementation on body composition in young athletes.
    Ostojic SM; Calleja J; Jourkesh M
    Chin J Physiol; 2010 Feb; 53(1):19-25. PubMed ID: 21789881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dehydroepiandrosterone and body fat.
    Clore JN
    Obes Res; 1995 Nov; 3 Suppl 4():613S-616S. PubMed ID: 8697065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dehydroepiandrosterone circulating levels in premenopausal obese women with very high body mass index.
    De Pergola G; Giagulli VA; Garruti G; Cospite MR; Giorgino F; Cignarelli M; Giorgino R
    Metabolism; 1991 Feb; 40(2):187-90. PubMed ID: 1824869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.
    Aoki K; Terauchi Y
    Vitam Horm; 2018; 108():355-365. PubMed ID: 30029734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yohimbine does not affect fat distribution in men.
    Sax L
    Int J Obes; 1991 Sep; 15(9):561-5. PubMed ID: 1960007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA).
    MacEwen EG; Kurzman ID
    J Nutr; 1991 Nov; 121(11 Suppl):S51-5. PubMed ID: 1834816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in body weight and cholesterol in spontaneously obese dogs by dehydroepiandrosterone.
    Kurzman ID; MacEwen EG; Haffa AL
    Int J Obes; 1990 Feb; 14(2):95-104. PubMed ID: 2140342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term DHEA administration in recreational athletes: impact on food intake, segmental body composition and adipokines.
    Gravisse N; Vibarel-Rebot N; Buisson C; Le Tiec C; Castanier C; Do MC; Gagey O; Audran M; Collomp K
    J Sports Med Phys Fitness; 2019 May; 59(5):808-816. PubMed ID: 30264977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antiobesity effect of dehydroepiandrosterone in rats.
    Cleary MP
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):8-16. PubMed ID: 1824576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans.
    Welle S; Jozefowicz R; Statt M
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1259-64. PubMed ID: 2146282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiobesity effect of dehydroepiandrosterone in castrated or noncastrated obese Zucker male rats.
    Taniguchi S; Yanase T; Haji M; Ishibashi K; Takayanagi R; Nawata H
    Obes Res; 1995 Dec; 3 Suppl 5():639S-643S. PubMed ID: 8653543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies.
    Tchernof A; Labrie F
    Eur J Endocrinol; 2004 Jul; 151(1):1-14. PubMed ID: 15248817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.